FABP2 and Fabry disease: The observed significant differences in various markers of intestinal mucosal permeability (LPS, Zonulin, DAO, and I-FABP) between FD patients with and without anxiety suggest that increased intestinal mucosal permeability may play a pivotal role in the exacerbation of symptoms in FD patients with anxiety.